Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and lessen the severity of illness, according to new research published in Cell.
Current seasonal influenza vaccines mainly target a different, more abundant influenza surface protein called hemagglutinin (HA). However, because influenza vaccines offer varying and sometimes limited protection, scientists are exploring ways to improve vaccine effectiveness. The new research builds on previous studies of NA and was conducted by a team of scientists including investigators from the Centers of Excellence for Influenza Research and Surveillance (CEIRS)program, which is organized and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Investigators analyzed blood samples from people vaccinated against influenza and people diagnosed with either the 2009 H1N1 influenza virus or H3N2 influenza viruses. The volunteers were recruited for this study or had taken part in prior influenza research studies. The analyses indicate that influenza vaccines rarely induce NA-reactive antibodies, whereas natural influenza infection induces these types of antibodies at least as often as they induce HA-reactive antibodies. Additional studies in mice reinforced the human data, indicating that current influenza vaccines do not induce NA-reactive antibodies efficiently.
Additional laboratory experiments show that the NA-reactive antibodies induced during natural influenza infection are broadly reactive, meaning they could potentially protect against diverse strains of influenza. To test this theory, scientists isolated NA-reactive monoclonal antibodies from the H3N2 and H1N1 influenza patients (N2-reactive antibodies and N1-reactive antibodies, respectively). They administered 13 N2-reactive antibodies to mice and subsequently infected the mice with a different H3N2 virus strain. Eleven of the 13 N2-reactive antibodies partially or fully protected the mice. They also administered eight N1-reactive antibodies to mice and subsequently infected the mice with a similar H1N1 virus strain or an H5N1-like virus strain. Four of the eight antibodies completely protected the mice against both virus strains.
The authors note that the findings suggest that influenza vaccines should be optimized to better target NA for broad protection against diverse influenza strains. In this regard, NIAID is supporting research to characterize NA responses in infected and vaccinated individuals and to determine the mechanism of action of NA protection. NIAID also supports “NAction!” a CEIRS working group that identifies knowledge gaps in our understanding of NA and sets NA research priorities for improved influenza vaccines. These efforts contribute to NIAID’s larger plan to develop a universal influenza vaccine—a vaccine that can durably protect all age groups against multiple influenza virus strains.
The Latest on: Influenza
via Google News
The Latest on: Influenza
- U.S. Influenza Diagnostics Market Worth USD 865.4 Million by 2024: Hexa Research on November 13, 2018 at 3:48 am
The U.S. influenza diagnostics market size is expected to reach USD 865.4 million by 2024. Influenza or flue is an infectious disease and affects the upper respiratory tract in humans. The disease ... […]
- Influenza Drug's Market Production: regional analysis for the United States, Europe, China, and Japan detailed in new research report on November 12, 2018 at 8:06 am
Global Influenza Drugs Market Report analyze the key factor like market status, market share, growth rate, future trends, market drivers, opportunities, challenges and more. Global Influenza Drugs Mar... […]
- What Are the Main Features for Influenza Diagnostics Market to Growing Fast in Global Industry from 2017-2022? on November 12, 2018 at 6:23 am
Influenza Diagnostics Market Research report forecast from 2017-2022 gives in-depth information of top Key players in their respective regions/countries. This report provides overview of Influenza Dia... […]
- Flagstaff History: Normal School reopens after influenza closure on November 11, 2018 at 1:15 am
1893: The people of Coconino County will make no desperate effort to get Arizona admitted to statehood, and if the county is represented at the Statehood Convention on the 27th, the delegate will ... […]
- Influenza Infection Increases Mortality Risk in Acute Myocardial Infarction on November 9, 2018 at 1:04 pm
Influenza infection independently increased the mortality risk in those who had acute myocardial infarction (AMI) but was not a risk factor for the development of AMI, according to research presented ... […]
- Canine influenza: Why you're not the only one who needs a flu shot on November 9, 2018 at 4:17 am
You aren't the only one in need of a flu shot. Your four-legged friend can benefit from the vaccine as well. (SNN) If you got your flu shot and think you're all set for flu season, think again. Canine ... […]
- The ‘Spanish’ influenza pandemic and its relation to World War I on November 8, 2018 at 9:50 am
A world-wide epidemic caused by influenza viruses led to between 50 and 100 million deaths in 1918 and 1919 (as much as one in every 18 people). Because neutral Spain was not censoring news, it became ... […]
- CDC Provides Influenza Updates, New Clinician Resources on November 7, 2018 at 1:45 pm
From May 20 to Oct. 13, 1.4 percent of the 197,295 respiratory specimens tested for influenza at U.S. clinical laboratories were positive -- about 65 percent of them positive for influenza A viruses a... […]
- Influenza Vaccines May Protect Against Lab-Confirmed Influenza-Linked Hospitalization During Pregnancy on November 7, 2018 at 6:12 am
During pregnancy, the use of influenza vaccines moderately protected against laboratory-confirmed influenza-linked hospitalization over the course of 6 influenza seasons, according to a Centers for Di... […]
via Bing News